(Q32158558)

6 July 2017

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia (English)

1 reference

6 July 2017

0 references

chronic schizophrenia

1 reference

Choe BY

1

1 reference

6 July 2017

Kim KT

2

1 reference

6 July 2017

Suh TS

3

1 reference

6 July 2017

Lee C

4

1 reference

6 July 2017

Paik IH

5

1 reference

6 July 2017

Bahk YW

6

1 reference

6 July 2017

Shinn KS

7

1 reference

6 July 2017

Lenkinski RE

8

1 reference

6 July 2017

1 November 1994

1 reference

6 July 2017

1 reference

6 July 2017

1

1 reference

6 July 2017

3

1 reference

6 July 2017

211-216

1 reference

Negative v positive schizophrenia. Definition and validation.

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

The heterogeneity of the long-term course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Qualitative assessment of brain morphology in acute and chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

A diagnostic interview: the schedule for affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

The neurochemistry of mania: a hypothesis of etiology and rationale for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Choline acetyltransferase in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Schizophrenic syndromes in epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Negative symptoms and hypofrontality in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

Rapid 31P spectroscopy on a 4-T whole-body system

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980716-0

7 January 2021

10.1016/S1076-6332(05)80716-0

Identifiers

DOI

1 reference

6 July 2017

1 reference